COP29 Japan Pavilion Side Event

Tackling Emerging Infectious Threats through Innovative Collaboration in the Era of Climate Change

15 November 2024 11:45-13:00(AZT)/ 16:45-18:00(JST)
Add to Calendar

Dengue fever is an infectious disease that the World Health Organization (WHO) named as one of the top 10 threats to global health in 2019. However, with no effective treatment, approximately half of the world's population is currently at risk of dengue fever, with an estimated 100 to 400 million people infected each year.

According to the WHO, before 1970, dengue was endemic in nine countries, mainly in Southeast Asia, but has now spread to more than 100 countries across a wide area in Latin America and the African continent. One of the reasons for the spread is the impact of climate change.
In this seminar, we will provide an overview of the intersection between climate change & health, and present the efforts of the private company to develop effective vaccines against infection, followed by a discussion with experts.

Through this seminar, representatives from the public and private sectors, as well as international organizations, will influence the audience in the seminar by absorbing knowledge and best practices and, creating possible cross-sector partnerships to develop workable solutions to address the increasing threat of dengue fever amidst climate challenges and health.

Event Details

Date/time
15 November 2024 11:45-13:00(AZT)/ 16:45-18:00(JST)
Venue

COP29 Japan Pavilion (Simultaneous Online Streaming available)

Languages
English / Japanese (Simultaneous interpretation)
(Simultaneous interpretation)

Presentation Materials

Event Details

Date/time
15 November 2024 11:45-13:00(AZT) / 16:45-18:00(JST)
Venue

Japan Pavilion in the Blue Zone at COP29, Baku, Azerbaijan

Languages
English / Japanese (Simultaneous interpretation)

Presentation Materials

 Opening Remarks
 MATSUZAWA Yutaka, Vice-Minister for Global Environmental Affairs, Ministry of the Environment, Japan 
 Keynote
 Maria Neira, Director of the Department of Public Health and Environment, WHO 
 Presentation
 OHYABU Takako, Global Corporate Affairs, Takeda Pharmaceutical Company Limited Chief Global Corporate Affairs and Sustainability Officer 
 Panel Discussion
 HAISA Yukihiro, Director, Climate Change Science and Adaptation Office, Global Environment Bureau, MOEJ 
Derek Wallace, Global Vaccine Business Unit, Takeda Pharmaceutical Company Limited President, Global Vaccine Business Unit 
Anamaria Bejar, GAVI Director, Public Policy Engagement 
Danilo Moura, Programme Specialist – Climate, Environment, and DRR (Disaster Risk Reduction) UNICEF Brasil 
TAKAHASHI Junichi, Director, Office of Global Health Cooperation, Ministry of Health, Labour and Welfare of Japan 
 Closing remarks
 HAISA Yukihiro, Director, Climate Change Science and Adaptation Office, Global Environment Bureau, MOEJ